Literature DB >> 28265858

Palbociclib inhibits proliferation of human adrenocortical tumor cells.

Chiara Fiorentini1, Martina Fragni1, Guido A M Tiberio2, Diego Galli1, Elisa Roca3, Valentina Salvi4, Daniela Bosisio4, Cristina Missale1, Massimo Terzolo5, Maurizio Memo1, Alfredo Berruti6, Sandra Sigala1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28265858     DOI： 10.1007/s12020-017-1270-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  19 in total

1.  Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells.

Authors:  Maria Cristina De Martino; Peter M van Koetsveld; Richard A Feelders; Steven W J Lamberts; Wouter W de Herder; Annamaria Colao; Rosario Pivonello; Leo J Hofland
Journal:  Endocrine       Date:  2015-12-08       Impact factor: 3.633

2.  Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  A Berruti; E Baudin; H Gelderblom; H R Haak; F Porpiglia; M Fassnacht; G Pentheroudakis
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

3.  Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Authors:  Alfredo Berruti; Massimo Terzolo; Paola Sperone; Anna Pia; Silvia Della Casa; David J Gross; Carlo Carnaghi; Paolo Casali; Francesco Porpiglia; Franco Mantero; Giuseppe Reimondo; Alberto Angeli; Luigi Dogliotti
Journal:  Endocr Relat Cancer       Date:  2005-09       Impact factor: 5.678

Review 4.  Molecular pathways: CDK4 inhibitors for cancer therapy.

Authors:  Mark A Dickson
Journal:  Clin Cancer Res       Date:  2014-05-02       Impact factor: 12.531

5.  Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study.

Authors:  Chiara Fiorentini; Martina Fragni; Paola Perego; Sara Vezzoli; Sara A Bonini; Monica Tortoreto; Diego Galli; Melanie Claps; Guido A Tiberio; Massimo Terzolo; Cristina Missale; Maurizio Memo; Giuseppe Procopio; Nadia Zaffaroni; Alfredo Berruti; Sandra Sigala
Journal:  J Clin Endocrinol Metab       Date:  2016-09-14       Impact factor: 5.958

6.  Gene expression profile of prostate cancer cell lines: effect of nerve growth factor treatment.

Authors:  S Sigala; S Bodei; C Missale; D Zani; C Simeone; S Cosciani Cunico; P F Spano
Journal:  Mol Cell Endocrinol       Date:  2008-01-08       Impact factor: 4.102

7.  Integrated genomic characterization of adrenocortical carcinoma.

Authors:  Guillaume Assié; Eric Letouzé; Martin Fassnacht; Anne Jouinot; Windy Luscap; Olivia Barreau; Hanin Omeiri; Stéphanie Rodriguez; Karine Perlemoine; Fernande René-Corail; Nabila Elarouci; Silviu Sbiera; Matthias Kroiss; Bruno Allolio; Jens Waldmann; Marcus Quinkler; Massimo Mannelli; Franco Mantero; Thomas Papathomas; Ronald De Krijger; Antoine Tabarin; Véronique Kerlan; Eric Baudin; Frédérique Tissier; Bertrand Dousset; Lionel Groussin; Laurence Amar; Eric Clauser; Xavier Bertagna; Bruno Ragazzon; Felix Beuschlein; Rossella Libé; Aurélien de Reyniès; Jérôme Bertherat
Journal:  Nat Genet       Date:  2014-04-20       Impact factor: 38.330

Review 8.  Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.

Authors:  Robert Roskoski
Journal:  Pharmacol Res       Date:  2016-03-16       Impact factor: 7.658

9.  Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells.

Authors:  Dayana B Rivadeneira; Christopher N Mayhew; Chellappagounder Thangavel; Elena Sotillo; Christopher A Reed; Xavier Graña; Erik S Knudsen
Journal:  Gastroenterology       Date:  2010-01-25       Impact factor: 22.682

10.  Molecular screening for a personalized treatment approach in advanced adrenocortical cancer.

Authors:  Maria Cristina De Martino; Abir Al Ghuzlan; Sebastien Aubert; Guillaume Assié; Jean-Yves Scoazec; Sophie Leboulleux; Christine Do Cao; Rossella Libè; Cécile Nozières; Marc Lombès; François Pattou; Francoise Borson-Chazot; Ségolène Hescot; Clement Mazoyer; Jacques Young; Isabelle Borget; Annamaria Colao; Rosario Pivonello; Jean-Charles Soria; Jerome Bertherat; Martin Schlumberger; Ludovic Lacroix; Eric Baudin
Journal:  J Clin Endocrinol Metab       Date:  2013-08-26       Impact factor: 5.958
View more
  11 in total

1.  Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma.

Authors:  Dipika R Mohan; Antonio Marcondes Lerario; Tobias Else; Bhramar Mukherjee; Madson Q Almeida; Michelle Vinco; Juilee Rege; Beatriz M P Mariani; Maria Claudia N Zerbini; Berenice B Mendonca; Ana Claudia Latronico; Suely K N Marie; William E Rainey; Thomas J Giordano; Maria Candida B V Fragoso; Gary D Hammer
Journal:  Clin Cancer Res       Date:  2019-02-15       Impact factor: 12.531

2.  Targeted genomic analysis of 364 adrenocortical carcinomas.

Authors:  Nikita Pozdeyev; Lauren Fishbein; Laurie M Gay; Ethan S Sokol; Ryan Hartmaier; Jeffrey S Ross; Sourat Darabi; Michael J Demeure; Adwitiya Kar; Lindsey J Foust; Katrina Koc; Daniel W Bowles; Stephen Leong; Margaret E Wierman; Katja Kiseljak-Vassiliades
Journal:  Endocr Relat Cancer       Date:  2021-08-16       Impact factor: 5.900

Review 3.  Adrenocortical carcinoma - towards genomics guided clinical care.

Authors:  Joakim Crona; Felix Beuschlein
Journal:  Nat Rev Endocrinol       Date:  2019-09       Impact factor: 43.330

Review 4.  Advances in adrenal tumors 2018.

Authors:  J Crona; F Beuschlein; K Pacak; B Skogseid
Journal:  Endocr Relat Cancer       Date:  2018-07       Impact factor: 5.678

Review 5.  Therapeutic Targets for Adrenocortical Carcinoma in the Genomics Era.

Authors:  Dipika R Mohan; Antonio Marcondes Lerario; Gary D Hammer
Journal:  J Endocr Soc       Date:  2018-09-26

6.  Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.

Authors:  Suraya Bondy; Camilla Tajzler; Sebastien J Hotte; Anil Kapoor; Kevin Zbuk; Aly-Khan A Lalani
Journal:  Curr Oncol       Date:  2020-12-31       Impact factor: 3.677

Review 7.  Current Status and Future Targeted Therapy in Adrenocortical Cancer.

Authors:  George Alyateem; Naris Nilubol
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-01       Impact factor: 6.055

Review 8.  Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.

Authors:  Omair A Shariq; Travis J McKenzie
Journal:  Ther Adv Chronic Dis       Date:  2021-07-20       Impact factor: 5.091

9.  Drug repurposing using high-throughput screening identifies a promising drug combination to treat adrenocortical carcinoma.

Authors:  Antonio M Lerario; Gary D Hammer
Journal:  Oncotarget       Date:  2018-09-07

10.  Targeted Gene Expression Profile Reveals CDK4 as Therapeutic Target for Selected Patients With Adrenocortical Carcinoma.

Authors:  Raimunde Liang; Isabel Weigand; Juliane Lippert; Stefan Kircher; Barbara Altieri; Sonja Steinhauer; Constanze Hantel; Simone Rost; Andreas Rosenwald; Matthias Kroiss; Martin Fassnacht; Silviu Sbiera; Cristina L Ronchi
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-16       Impact factor: 5.555
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.